Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jpba.2013.09.006
DC FieldValue
dc.titleSimultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography/tandem mass spectrometry and its application to pharmacokinetic study
dc.contributor.authorHee, K.H.
dc.contributor.authorYao, Z.
dc.contributor.authorLee, L.S.
dc.date.accessioned2016-09-06T08:42:14Z
dc.date.available2016-09-06T08:42:14Z
dc.date.issued2014-01-25
dc.identifier.citationHee, K.H., Yao, Z., Lee, L.S. (2014-01-25). Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography/tandem mass spectrometry and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 88 : 584-593. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jpba.2013.09.006
dc.identifier.issn07317085
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/126856
dc.description.abstractCytochrome P450 3A4 (CYP3A4) and UDP-glucuronosyltransferase 1A1 (UGT1A1) are important enzymes responsible for the metabolism of many xenobiotics. To investigate their induction and inhibition properties, administering probe drugs and monitoring their concentration in plasma under the effects of inducers/inhibitors is the gold standard method. A rapid and sensitive liquid chromatography-tandem mass spectrometry method was developed for simultaneous quantification of midazolam, raltegravir (probe drugs for CYP3A4 and UGT1A1), their major metabolites, 1'-hydroxymidazolam, 1'-hydroxymidazolam glucuronide and raltegravir glucuronide, rifampicin (inducer), ritonavir and ketoconazole (inhibitors). Analytes were extracted from 100μl of plasma using solid-phase extraction followed by chromatographic separation on a reversed-phase C18 column (50mm×2.1mm, particle size 1.8μm). The mass spectrometer was operated under positive ionization mode. Excellent linearity (r2≥0.995) was achieved for all. The method was validated and found to be accurate (88-111%), precise (CV%
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.jpba.2013.09.006
dc.sourceScopus
dc.subjectKetoconazole
dc.subjectMidazolam
dc.subjectRaltegravir
dc.subjectRifampin
dc.subjectRitonavir
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.jpba.2013.09.006
dc.description.sourcetitleJournal of Pharmaceutical and Biomedical Analysis
dc.description.volume88
dc.description.page584-593
dc.description.codenJPBAD
dc.identifier.isiut000329532800077
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

6
checked on May 24, 2022

WEB OF SCIENCETM
Citations

3
checked on May 24, 2022

Page view(s)

135
checked on May 26, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.